Diabetic nephropathy (DN) is a long-standing complication of diabetes caused by accumulating injury to the glomerular microvasculature of the kidneys. DN is frequently asymptomatic, particularly in early stages, but can be detected using annual kidney-function and albuminuria tests.
Your search for smoking cessation returned 23 results
In January, 2016, the American Association of Clinical Endocrinologists/American College of Endocrinology (AAACE/ACE) released their 2016 Comprehensive Type 2 Diabetes Management Algorithm, which serves as an update to the earlier 2013 algorithm.
A recent review article summarizes current nonpharmacologic and pharmacologic approaches to hypertriglyceridemia, with particular focus on novel agents.
Familial hypercholesterolemia (FH), an inherited genetic disorder characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) levels, affects an estimated 620,000 Americans and is generally underdiagnosed and undertreated.
The American Heart Association (AHA), the American College of Cardiology (ACC), and the American Society of Hypertension (ASH) have issued a new scientific statement entitled “Treatment of Hypertension in Patients with Coronary Heart Disease.” This article features an interview with Clive Rosendorff, MD, PhD, DScMed, chair of the writing committee, who discusses what’s new in the guideline, and addresses areas of controversy.
Multiple studies show that just about any low-meat or no-meat diet reduces almost all controllable risk factors for cardiovascular disease.
E-cigarettes have gained popularity over the last few years, but are they really as safe as people may think?
The most recent guidelines from the American College of Rheumatology include pharmacologic and nonpharmacologic therapy for hyperuricemia.
Obesity is rising at an alarming rate in the United States. Combined with hypertension, the two present an enormous risk of both morbidity and mortality. A leading researcher addresses the issues raised with this timely issue.
Experts advise that new consumer-targeted cancer-screening apps may put patients at risk.